Literature DB >> 17981419

Imaging findings of liver involvement of Wilson's disease.

Okan Akhan1, Erhan Akpinar, Musturay Karcaaltincaba, Mithat Haliloglu, Deniz Akata, Ali Devrim Karaosmanoglu, Mustafa Ozmen.   

Abstract

PURPOSE: The major purpose of this paper is to outline and correlate US, CT and MR imaging findings of liver in patients with Wilson's disease.
MATERIALS AND METHODS: Twenty-eight patients (10 male, 18 female, median age 16) with Wilson's disease were examined with US, CT and MRI. Liver echogenicity, echo pattern, contour irregularity, periportal thickness, perihepatic fat layer thickness, the presence of focal parenchymal lesion, and other associated findings were recorded by US in every patient. CT and MRI were done in 20 and 12 patients, respectively.
RESULTS: Contour irregularity was observed in 24 patients and heterogeneous parenchymal echo pattern was seen in 26 patients with US. The presence of increased perihepatic fat layer was observed in eight patients. Severe parenchymal atrophy was seen in all lobes of the liver including caudate in contrast to post-viral chronic liver disease. Nineteen patients had periportal thickening. US showed multiple hyper and/or hypoechoic nodules smaller than 1cm in 13 patients. MRI demonstrated small nodular hypointense areas on T2-weighted images in five patients. In only one patient these nodules showed contrast enhancement in CT and MR and pathologically proved to be dysplastic nodule.
CONCLUSION: Wilson's disease involving the liver has several unique radiological findings in comparison to other types of cirrhosis. These specific features include multiple nodular lesions in the liver, presence of perihepatic fat layer and normal caudate lobe which is contrary to other types cirrhosis. Liver injury in the Wilson's disease can be defined by imaging modalities, especially by US which we think is the most precise imaging modality to detect early parenchymal changes in the progress of the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17981419     DOI: 10.1016/j.ejrad.2007.09.029

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

1.  MR imaging features of liver involvement by Wilson disease in adult patients.

Authors:  Ottavia Vargas; Sid Ahmed Faraoun; Raphael Dautry; Youcef Guerrache; France Woimant; Lounis Hamzi; Mourad Boudiaf; Aurelia Poujois; Philippe Soyer; Anthony Dohan
Journal:  Radiol Med       Date:  2016-04-22       Impact factor: 3.469

Review 2.  [Diffuse and vascular hepatic diseases].

Authors:  S Kreimeyer; L Grenacher
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

Review 3.  Other types of diffuse liver disease: is there a way to do it?

Authors:  Hilton Leao Filho; Camila Vilela de Oliveira; Natally Horvat
Journal:  Abdom Radiol (NY)       Date:  2020-11

4.  Diagnostic challenges of Wilson's disease presenting as acute pancreatitis, cholangitis, and jaundice.

Authors:  Elchanan Nussinson; Azmi Shahbari; Fahmi Shibli; Elena Chervinsky; Philippe Trougouboff; Arie Markel
Journal:  World J Hepatol       Date:  2013-11-27

Review 5.  Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics.

Authors:  Kumi Ozaki; Kazuto Kozaka; Yasuo Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-04-28       Impact factor: 2.374

6.  Clinical application of liver MR imaging in Wilson's disease.

Authors:  Jung-Eun Cheon; In-One Kim; Jeong Kee Seo; Jae Sung Ko; Jeong Min Lee; Cheong-Il Shin; Woo Sun Kim; Kyung Mo Yeon
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

Review 7.  Update on the clinical management of Wilson's disease.

Authors:  Peter Hedera
Journal:  Appl Clin Genet       Date:  2017-01-13

8.  Importance of a Liver Biopsy in the Management of Wilson Disease.

Authors:  Shinji Oe; Yuichi Honma; Kei Yabuki; Kahori Morino; Keiichiro Kumamoto; Tsuguru Hayashi; Masashi Kusanaga; Noriyoshi Ogino; Sota Minami; Michihiko Shibata; Shintaro Abe; Masaru Harada
Journal:  Intern Med       Date:  2019-09-11       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.